加尔纳克终端覆盖的多 (β-氨基) 具有屏蔽侧链,用于高效的基因传递
Xinlong Liu1, Yimeng Li1, Xinhua Liu2
1School of Chemistry and Chemical Engineering, Frontiers Science Center for Transformative Molecules, Shanghai Key Laboratory for Molecular Engineering of Chiral Drugs, Shanghai Jiao Tong University, Shanghai, 200240, China.
Small methods
|March 3, 2025
概括
研究人员开发了新型的聚β-氨基 (PBAE) 与N-乙黄胺 (GalNAc) 进行高效的基因疗法. 这些GalNAc-PBAE向肝脏,减少纤维化,并改善小鼠的肝功能.
科学领域:
- 生物材料科学 生物材料科学
- 基因治疗 基因治疗
- 纳米技术纳米技术
背景情况:
- 等离子体是基因治疗的关键载体,但有效的输送是一个重大障碍.
- 聚β氨基 (PBAE) 显示出非病毒基因传递的前景,但面临毒性和向限制.
研究的目的:
- 设计和合成一种具有二硫化键和N-乙银胺 (GalNAc) 的新型PBAE,用于增强等离子体输送和向肝脏.
- 在肝纤维化模型中评估新型GalNAc-PBAE的转染效率,毒性和治疗疗效.
主要方法:
- 合成具有二硫化键和三级胺侧链的新型GalNAc终结PBAE.
- 在体外转染效率测定和与商业试剂的比较.
- 在急性肝纤维化小鼠模型中的体内研究,使用编码HGF的等离子体.
主要成果:
- 优化的GalNAc-PBAE与基准PBAE (C28-E7) 和Lipo2000.7相比,显示出更高的传染效率.
- GalNAc部分促进了等离子体-PBAE复合体的高效肝脏向.
- 在体内给药显著减轻了小鼠的肝纤维化和改善了肝功能.
结论:
- 新型GalNAc-PBAE是一种有前途的非病毒载体,可以有效地输送等离子体和基因疗法,特别是在肝脏疾病中.
- 设计的PBAE克服了传统载体的局限性,提供了更高的疗效和组织特异性向.
- 这种GalNAc-PBAE在治疗肝纤维化和其他肝脏疾病方面具有临床翻译的潜力.
更多相关视频
相关概念视频
Genomic DNA in Eukaryotes
Eukaryotes have large genomes compared to prokaryotes. To fit their genomes into a cell, eukaryotic DNA is packaged extraordinarily tightly inside the nucleus. To achieve this, DNA is tightly wound around proteins called histones, which are packaged into nucleosomes that are joined by linker DNA and coil into chromatin fibers. Additional fibrous proteins further compact the chromatin, which is recognizable as chromosomes during certain phases of cell division.
Position-effect Variegation
In 1928, a German botanist Emil Heitz observed the moss nuclei with a DNA binding dye. He observed that while some chromatin regions decondense and spread out in the interphase nucleus, others do not. He termed them euchromatin and heterochromatin, respectively. He proposed that the heterochromatin regions reflect a functionally inactive state of the genome. It was later confirmed that heterochromatin is transcriptionally repressed, and euchromatin is transcriptionally active chromatin.
Long-patch Base Excision Repair
Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:
Gene Conversion
Other than maintaining genome stability via DNA repair, homologous recombination plays an important role in diversifying the genome. In fact, the recombination of sequences forms the molecular basis of genomic evolution. Random and non-random permutations of genomic sequences create a library of new amalgamated sequences. These newly formed genomes can determine the fitness and survival of cells. In bacteria, homologous and non-homologous types of recombination lead to the evolution of new...
Conjugation
Conjugation is a form of horizontal gene transfer that primarily occurs in bacteria and some archaea, promoting genetic diversity and adaptation. Bacteria can acquire resistance genes through conjugative plasmids, allowing them to survive antibiotic treatments that would otherwise be lethal. This process involves direct contact between cells through specialized structures such as the sex pilus and is mediated by conjugative plasmids, including the F (fertility) factor.Conjugation requires...


